Liquid chromatography⿿tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O⿿ desmethyl metabolites of erlotinib and gefitinib in human plasma

Published 2016 View Full Article

Title

Liquid chromatography⿿tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O⿿ desmethyl metabolites of erlotinib and gefitinib in human plasma

Authors

Keywords

Afatinib, Erlotinib, Gefitinib, Encorafenib, LC⿿MS/MS, Plasma

Journal

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Volume 1033-1034, Issue -, Pages 390-398

Publisher

Elsevier BV

Online

2016-09-13

DOI

10.1016/j.jchromb.2016.09.012

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

© Peeref 2019-2024. All rights reserved.